Anup Malani : Publications
The Future of Healthcare Reform in the United States. (University of Chicago Press, 2015) (edited with Michael H. Schill).
Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance. (Resources for the Future, 2007) (edited with Ramanan Laxminarayan, David Howard & David Smith). [CU]
"Interpreting Pre-Trends as Anticipation: Impact on Estimated Treatment Effects from Tort Reform," 124 Journal of Public Economics 1 (2015) (with Julian Reif). [CU]
"The Need for Better Evidence to Evaluate the Health & Economic Benefits of India's Rashtriya Swasthya Bima Yojana," 142 Indian Journal of Medical Research 383 (2015) (with Arindam Nandi, E. Phoebe Holtzman & Ramanan Laxminarayan). [CU]
"Incentives for Reporting Disease Outbreaks," 9 PLoS ONE 1 (2014) (with Ramanan Laxminarayan & Julian Reif ). [CU]
"Trial Court Budgets, the Enforcer's Dilemma, and the Rule of Law," 2014 University of Illinois Law Review 1573 (2014) (with Scott Baker). [CU] [WWW]
"Renegotiation Design by Contract," 81 University of Chicago Law Review 151 (2014) (with Richard T. Holden). [CU]
"Advertisements Impact the Physiological Efficacy of a Branded Drug," 110 Proceedings of the National Academy of Sciences of the United States of America 12931 (2013) (with Emir Kamenica & RobertNaclerio ). [CU]
"Policy Preferences and Legal Interpretation," 1 Journal of Law and Courts 115 (2013) (with Ward Farnsworth & Dustin F. Guzior). [CU]
"Economic Epidemiology of Avian Influenza on Smallholder Poultry Farms," 90 Theoretical Population Biology 135 (2013) (with Maciej Boni & Alison Galvani & Abraham Wickelgren ). [CU]
"The Hot–Cold Decision Triangle: A Framework for Healthier Choices," 23 Marketing Letters 457 (2012) (with Haiyang Yang, Ziv Carmon, Barbara Kahn & Janet Schwartz, Kevin Volpp & Brian Wansink). [CU]
"Accounting for Heterogeneous Treatment Effects in the FDA Approval Process," 67 Food and Drug Law Journal 23 (2012) (with Oliver Van Der Bembom & Mark van der Laan). [CU]
"Incentives for Reporting Infectious Disease Outbreaks," 46 Journal of Human Resources 176 (2011) (with Ramanan Laxminarayan). [CU]
"Valuing Laws as Local Amenities," 121 Harvard Law Review 1273 (2008). [CU]
"Antibiotic Overuse: The Influence of Social Norms," 207 Journal of the American College of Surgeons 265 (2008) (with Timothy G. Buchman & Jonathan Dushoff & Mark B. Effron & Paul R. Ehrlich & Susan Fitzpatrick & Ramanan Laxminarayan & Bruce Levin & Simon A. Levin & Marc Lipsitch ) (Other authors: Carol Nemeroff, Sarah P. Otto, Vimla L. Patel, and Joseph S. Solomkin). [CU]
"Regulation with Placebo Effects," 58 Duke Law Journal 411 (2008). [CU]
"Does Nonprofit Status Signal Quality?," 37 Journal of Legal Studies 551 (2008) (with Guy David). [CU]
"Current Research on Medical Malpractice Liability," 36 Journal of Legal Studies S1 (2007). [CU]
"The Case for For-Profit Charities," 93 Virginia Law Review 2017 (2007) (with Eric Posner). [CU]
"Habeas Settlements," 92 Virginia Law Review 1 (2006). [CU]
"Determinants of Direct Foreign Investment and Its Connection to Trade," 1994 UNCTAD Review 39 (1994) (with Gary Hufbauer & Darius Lakdawalla). [CU]
"The Complex Relationship between Healthcare Reform and Innovation," in The Future of Healthcare Reform in the United States, Michael H. Schill & Anup Malani eds. (University of Chicago Press, 2015) (with Darius Lakdawalla & Julian Reif).
"The Complex Relationship between Healthcare Reform and Innovation," in The Future of Healthcare Reform in the United States, Michael H. Schill & Anup Malani eds. (University of Chicago Press, 2015).
"Introduction," in The Future of Healthcare Reform in the United States, Anup Malani & Michael H. Schill eds. (University of Chicago Press, 2015) (with Michael H. Schill).
"The Welfare Effects of FDA Regulation of Drugs," in The Oxford Handbook of the Economics of the Biopharmaceutical Industry, Patricia Danzon & Sean Nicholson eds. (2012) (with Tomas J. Philipson). [CU]
"Commentary (commenting on Jessica L. Cohen and William T. Dickens, Adoption of Over-the-Counter Malaria Diagnostics in Africa: The Role of Subsidies, Beliefs, Externalities,and Competition (2012))," in The Value of Information: Methodological Frontiers and New Applications in environment and Health, Ramanan Laxminarayan & Molly K. Macauley eds. (Springer, 2012). [CU]
"Economics of Infectious Diseases," in The Oxford Handbook of Health Economics, Sherry Glied & Peter C. Smith eds. (2011) (with Ramanan Laxminarayan). [CU]
"Comment on Chapter 3 (Burman, Garrett and Khitatrakun)," in Conference on Taxes and Health Insurance: Analysis and Policy, Leonard E. Burman & Robert B. Helms eds. (Brookings Institution Press, 2008). [CU]
"Firm Behavior in the Non-Profit Sector: A Synthesis and Empirical Evaluation," in The Governance of Not-for-Profit Firms, Edward L Glaeser ed. (NBER/University of Chicago Press, 2003). [CU]
"The Insurance Value of Medical Innovation," NBER Working Paper, No. 21015 (2015) (with Darius Lakdawalla & Julian Reif). [WWW]
Best of Both Worlds Uniting Universal Coverage and Personal Choice in Health Care, (American Enterprise Institute). 2013) (with Jayanta Bhattacharya & Amitabh Chandra & Michael Chernew ). [CU]
"Pay-for-delay or pay-for-innovation?," Forbes Online, July 15, 2010. [WWW]
"Capitalism 2.0," Forbes Online, March 10, 2008 (with M. Todd Henderson). [WWW]
(2003) (PhD dissertation, University of Chicago).